Xcellerex
Get Full AccessDescription
- Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized.Xcellerex is built around a unique biomanufacturing platform that features the innovative application of single-use component technology. The Xcellerex platform transforms biomanufacturing economics by enabling:> Faster deployment of new manufacturing capacity: 12-18 months vs. 3-5 years.> Reduced capital investment: Typical savings of 50% to 70% compared to conventional approaches.> Unmatched flexibility: Modular microenvironment approach enables fast, low-cost redeployment for multi-drug production.Xcellerex offers a suite of world-class products and services to support the adoption of its platform. These include the XDR line of single-use bioreactors, PDMax® high-throughput process development and optimization services, and proven GMP manufacturing operated by an experienced CMC team. The company also actively seeks creative partnerships to facilitate access to the platform.
-
Headquarters:170 Locke Drive , Marlborough, Massachusetts, United States
More -
Phone Number: +1 508-480-9235
-
Website: https://www.xcellerex.com
-
Employees:29
-
Revenue:$1 - 10M
-
Legal Name:Xcellerex
-
Xcellerex's Social Media
- Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Xcellerex
-
Where are Xcellerex's Headquarters?
Xcellerex's Headquarters are in 170 Locke Drive ,Marlborough,Massachusetts,United States
-
What is Xcellerex's phone number?
Xcellerex's phone number is +1 508-480-9235
-
What is Xcellerex's official website?
Xcellerex's official website is https://www.xcellerex.com
-
What is Xcellerex's Revenue?
Xcellerex's revenue is $1 - 10M
-
What is Xcellerex's NAICS code?
Xcellerex's NAICS code is 325412
-
How many employees are working in Xcellerex
Xcellerex has 29 employees
-
What is Xcellerex's Industry?
Xcellerex is in the industry of Pharmaceuticals
-
Who is Xcellerex's Vice President Vaccine And Drug Development?
Xcellerex's Vice President Vaccine And Drug Development is Dennis Trent